Hemab Therapeutics Hldgs Q1 EPS $(23.98) Down From $(16.18) YoY
Benzinga Newsdesk 5 months ago
EarningsNews
Hemab Therapeutics Hldgs (NASDAQ:COAG) reported quarterly losses of $(23.98) per share. This is a 48.21 percent decrease over losses of $(16.18) per share from the same period last year.
Hemab Therapeutics Hldgs (NASDAQ:COAG) reported quarterly losses of $(23.98) per share. This is a 48.21 percent decrease over losses of $(16.18) per share from the same period last year.